GSK flags pharma M&A ambitions by poaching Roche deal-maker

LONDON (Reuters) – GlaxoSmithKline signaled its intention to boost its drug pipeline through deals on Wednesday by hiring Kevin Sin from Roche’s Genentech unit to lead a worldwide search for promising experimental products.

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *